Search Results 191-200 of 16994 for ozempic

  1. Insulin Regulation of Lipolysis and Lipolysis Proteins - Mayo Clinic

    About this study. The purpose of this study is to determine whether impaired insulin-induced suppression of lipolysis (as measured by IC50) is related to ...

  2. Glyburide and metformin (oral route) - Mayo Clinic

    It is used together with a proper diet and exercise to help control blood sugar levels. Glyburide causes your pancreas to release more insulin into the ...

  3. Ependymoma - Doctors and departments - Mayo Clinic

    Learn about this tumor that forms from ependymal cells in the brain and spinal cord. Treatments include surgery, radiation therapy and chemotherapy.

  4. Imiglucerase (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  5. Moexipril and hydrochlorothiazide (oral route) - Side effects & dosage - Mayo Clinic

    This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. Lowering blood pressure reduces the ...

  6. Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype - Mayo Clinic

    The purpose of this study is to evaluate the effect of IC-CBAS 1000 mg BID on EEC function, weight loss, satiety perception, and satiety GI hormones, in ...

  7. Connected Health Care in Exercise Program for Obesity - Mayo Clinic

    About this study. Many kinds of wearable technology have become available, but the superiority of those devices in weight loss compared to the standard care ...

  8. A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES) - Mayo Clinic

    A Randomized, Double-blind, Placebo-controlled Study to Investigate the Efficacy and Safety of Depemokimab in Adults With Hypereosinophilic Syndrome (HES).

  9. Pazopanib as Front-Line Therapy in Patients With Non-Resectable or Metastatic Soft Tissue Sarcomas Who Are Not Candidates for Chemotherapy - Mayo Clinic

    About this study. Pazopanib is FDA approved as a second line and beyond treatment for metastatic soft tissue sarcoma. There is a population of elderly and ...

  10. Ixazomib Plus Pomalidomide and Dexamethasone in Treating Patients with Relapsed or Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    Giving ixazomib with pomalidomide and dexamethasone may be an effective treatment for relapsed or relapsed/refractory multiple myeloma. Participation ...